Detalhe da pesquisa
1.
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.
Rheumatol Int
; 44(1): 73-80, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060005
2.
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey.
Rheumatol Int
; 44(1): 89-97, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668836
3.
Predictors of long-term functional outcomes of juvenile idiopathic arthritis-enthesitis-related arthritis: a single centre experience.
Rheumatology (Oxford)
; 62(9): 3110-3116, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702467
4.
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey.
Rheumatology (Oxford)
; 62(3): 1204-1215, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35920795
5.
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey.
Rheumatol Int
; 43(9): 1637-1649, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314497
6.
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.
Rheumatol Int
; 43(1): 47-58, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36271958
7.
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study.
Rheumatol Int
; 43(9): 1651-1664, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37351634
8.
Gender differences in patient experience in idiopathic inflammatory myopathies: Sub analysis from the COVAD dataset.
Mod Rheumatol
; 2023 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769200
9.
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study.
Rheumatology (Oxford)
; 62(1): 65-76, 2022 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35713499
10.
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies.
Muscle Nerve
; 66(4): 426-437, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869701
11.
COVAD survey 2 long-term outcomes: unmet need and protocol.
Rheumatol Int
; 42(12): 2151-2158, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35964271
12.
Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study.
J Diabetes Investig
; 15(1): 131-138, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37697820
13.
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group.
Int J Rheum Dis
; 27(5): e15178, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38742751